《亚洲经济》新加坡4月PMI由逾两年半高续降至51.8
IHS Markit数据显示,新加坡今年4月采购经理人指数(PMI)由逾两年半高位连续第二个月回顺,由前值53.5,续降至51.8,反映私企业务状况增速进一步放缓,但已连续第五个月处於扩张水平之上。
期内,新订单指数增速由两年半高位连续第二个月放缓至四个月低;产出指数连增五个月;但新出口订单重陷轻微收缩,结束连续两个月扩张;企业削减员工人数。采购成本通胀加速升至去年8月以来最快;产出费用连增三个月。不过,企业对来年业务前景信心由前值所创四个月低位有所改善。
上述PMI包括新加坡私企的制造业、服务业、建筑业及零售业。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.